GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 96 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,730,000 | +2454.2% | 700,015 | +1418.1% | 0.34% | +1100.0% |
| Q3 2020 | $655,000 | +186.0% | 46,110 | +196.7% | 0.03% | +154.5% |
| Q2 2020 | $229,000 | -55.8% | 15,541 | -85.6% | 0.01% | -52.2% |
| Q4 2019 | $518,000 | -30.5% | 107,750 | -12.4% | 0.02% | -11.5% |
| Q3 2019 | $745,000 | +138.8% | 122,981 | +155.7% | 0.03% | +188.9% |
| Q2 2019 | $312,000 | -57.9% | 48,099 | -23.2% | 0.01% | -60.9% |
| Q2 2017 | $741,000 | – | 62,652 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|